| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/14/2005 | US20050080038 Vaginal pharmaceutical compositions and methods for preparing them |
| 04/14/2005 | US20050080037 Methods for treating acute and overuse sprain and strain using hyaluronic acid |
| 04/14/2005 | US20050080036 Oral immunostimulation of mammals birds and reptiles from (1-4) linked beta-d-mannuronic acid |
| 04/14/2005 | US20050080035 Use of BVDU for inhibiting the growth of hyperproliferative cells |
| 04/14/2005 | US20050080034 Beta-L-2'-deoxynucleosides for the treatment of resistant HBV strains and combination therapies |
| 04/14/2005 | US20050080033 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 04/14/2005 | US20050080030 Amplifying efficiency of transfection, providing aggregation, exposing to vector, monitoring efficiency of transfection |
| 04/14/2005 | US20050080028 Ballast administering to mammals skins; high density core overcoated with amorphous reservoir containing dna; drug delivery; containing free radical scavenger |
| 04/14/2005 | US20050080026 Nucleic acid molecule of MAP kinase interacting kinase gene family or polypeptide encoded thereby or fragment or variant of nucleic acid molecule, polypeptide or antibody, aptamer or receptor recognizing a nucleic acid molecule of gene family or polypeptide encoded thereby; treating metabolic diseases |
| 04/14/2005 | US20050080025 Macrolides |
| 04/14/2005 | US20050080024 Can safely and effectively lower blood cholesterol while simultaneously decreasing endothelial dysfunction and decreasing vascular oxidative stress |
| 04/14/2005 | US20050080023 Osteoclastogenesis inhibitors and uses thereof |
| 04/14/2005 | US20050080022 substituted benzylphenol derivatives as intermediates for glucopyranosyloxybenzylbenzene derivatives; agents for the prevention or treatment of diabetes, diabetic complications, obesity or the like |
| 04/14/2005 | US20050080021 Nitric oxide donating derivatives of stilbenes, polyphenols and flavonoids for the treatment of cardiovascular disorders |
| 04/14/2005 | US20050080020 Hydroxylated indirubin derivatives |
| 04/14/2005 | US20050080019 Radiotherapy method using x-rays |
| 04/14/2005 | US20050080018 In particular, use of propionyl-L-carnitine in combination with one or more known useful drugs for preparing medicine for treatment of erectile dysfunction in patients suffering from diabetes mellitus, wherein patients do not respond to treatment with other useful drugs |
| 04/14/2005 | US20050080017 Viricide against hepatitis virus; pyrrole derivatives as, for example, 3-acetyl-4,5-dimethyl-2-pyrrole carboxylic acid |
| 04/14/2005 | US20050080012 Comprising controlled substance and amino acid or polypeptide covalently bound to controlled substance in manner that renders controlled substance pharmacologically inactive; when delivered by oral route controlled substance is released in time-dependent manner by acid hydrolysis and/or enzyme cleavage |
| 04/14/2005 | US20050080010 Suppression of immune response via inhibition of cathepsin S |
| 04/14/2005 | US20050080008 Administering bactericidal permeability increasing protein products; anticoagulants; without severe adverse side effects |
| 04/14/2005 | US20050080006 Apo2L/TRAIL formulations including lyophilized and crystal compositions; may be used in inducing apoptosis in mammalian cells including cancer cells by exposing mammalian cells to an effective amount of an Apo-2 ligand formulation described herein |
| 04/14/2005 | US20050079995 For treatment of cancers through activation of silenced tumor suppressor genes, promotion of apoptosis in cancerous cells, and inhibition of transcriptional repressor activity in oncogenes; drug screening |
| 04/14/2005 | US20050079597 Antimicrobial composition |
| 04/14/2005 | US20050079561 Detecting cancerous and precancerous cells; obtain tissue sample, incubate with tetrakis dyes, rinse and remove unbound dye, detect fluorescence, fuorescence indicates cancerous or precancerous cells |
| 04/14/2005 | US20050079541 Immunoadhesin comprising a glycorprotein v1 domain |
| 04/14/2005 | US20050079537 Expression vector comprising nucleotide sequences coding membrane protein for in identifying modulator for prevention and treatment of cell proliferative, nervous system and inflammatory disorders |
| 04/14/2005 | US20050079532 Methods and systems for identifying predisposition to the placebo effect |
| 04/14/2005 | US20050079502 Transplant rejection suppressor |
| 04/14/2005 | US20050079260 Methods for reducing astringency |
| 04/14/2005 | US20050079258 Phytosterol compositions |
| 04/14/2005 | US20050079235 Using green tea extract |
| 04/14/2005 | US20050079233 Using plant extracts |
| 04/14/2005 | US20050079232 Composition for promotion of bone growth and maintenance of bone health |
| 04/14/2005 | US20050079228 Clear, stable topical compositions of clarithromycin and processes for their preparation |
| 04/14/2005 | US20050079225 Methods and therapeutic compositions in the treatment of advanced cancer |
| 04/14/2005 | US20050079224 Residual solvent extraction method and microparticles produced thereby |
| 04/14/2005 | US20050079223 Method for obtaining novel lutein-based formulations |
| 04/14/2005 | US20050079217 Tablet with protective coatings; Parkinson's disease; sexual disorders |
| 04/14/2005 | US20050079216 Tablets, pellets in active matrix copolymer; melting, injection molding, extrusion, granulation |
| 04/14/2005 | US20050079213 Solid oral dosage form; cefuroxime axetil in capsule |
| 04/14/2005 | US20050079211 Use of lipid conjugates in the treatment of diseases of the nervous system |
| 04/14/2005 | US20050079209 Esters of L-carnitine of alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 04/14/2005 | US20050079206 Transdermal delivery system for the administration of rotigotine |
| 04/14/2005 | US20050079203 Obesity; antidiabetic agents ; insulin resistance; hypotensive agents; increase dopaminergic agents; controlling concentration of protein, fats, carbohydrates and calories |
| 04/14/2005 | US20050079187 Composition, kit and method for reducing plaque formation, tooth decay and incidence of caries |
| 04/14/2005 | US20050079180 Manipulatin of oocyte maturation and male germ cell survival |
| 04/14/2005 | US20050079178 Inhibitor of cardiac tachyarrhythmias |
| 04/14/2005 | US20050079176 Treating stress response with chemokine receptor ccr5 modulators |
| 04/14/2005 | US20050079173 Antibody that binds said inhibitor protein; interfering diagnostically or therapeutically with a wnt signal path; treatment of eye disorders, bone disorders, or tumors |
| 04/14/2005 | US20050079164 Solubilized CoQ-10 and carnitine |
| 04/14/2005 | US20050079159 Autologous tissue for connecting structures; regeneration of tissue; cell differentiation of pluripotent cells |
| 04/14/2005 | US20050079157 Combination bacteriolytic therapy for the treatment of tumors |
| 04/14/2005 | US20050079156 Method of treating endometreosis |
| 04/14/2005 | US20050079150 Biocidal polymers |
| 04/14/2005 | US20050079149 Hyperbranched dendron and methods of synthesis and use thereof |
| 04/14/2005 | US20050079148 Biocompatible polymer designed to release nitric oxide; extensively cross-linked polyamine-derivatized divinylbenzene; sustained release, potentiation |
| 04/14/2005 | US20050079147 Using poloxamer with buffer and excipient |
| 04/14/2005 | US20050079146 Mixture of ionic surfactant, chelate compound and solvent, preferable water; against grampositive, gramnegative bacteria |
| 04/14/2005 | US20050079145 Stabilized reverse micelle compositions and uses thereof |
| 04/14/2005 | US20050079144 Method for decreasing sebum production |
| 04/14/2005 | US20050079139 Minoxidil pharmaceutical foam formulation |
| 04/14/2005 | US20050079137 Heat resistant active material ; mixture with propylene glycol and an excipients |
| 04/14/2005 | US20050079136 Therapy for pain, appetite inttensifiers, multiple sclerosis and asthma; drug delivery |
| 04/14/2005 | US20050078179 Modulate aptamer and method for detecting target protein by using the same |
| 04/14/2005 | US20050076916 Condom |
| 04/14/2005 | DE202005000862U1 Dry composition, useful for providing nutrients required for healthy joints, with some ingredients in rapid-release form and others in slow-release form, in separate components |
| 04/14/2005 | DE19842833B4 2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung 2-arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole and 2-Arylalkinylthio-imidazoles as inflammatory inhibitors and inhibitors of cytokine release |
| 04/14/2005 | DE10345065A1 Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum Aerosol formulation for inhalation containing an anticholinergic |
| 04/14/2005 | DE10343365A1 Pharmazeutische Formulierungen von Xanthogenaten und Hemmstoffen der viralen Nukleinsäurereplikation Pharmaceutical formulations of xanthates and inhibitors of viral nucleic acid replication |
| 04/14/2005 | DE10342503A1 Benzyl-Benzimidazolylderivate Benzyl-Benzimidazolylderivate |
| 04/14/2005 | DE10342423A1 Verwendung von Fumarsäurederivaten zur Prophylaxe und zur Behandlung von Genomschäden The use of fumaric acid derivatives for the prophylaxis and treatment of genomic damage |
| 04/14/2005 | CA2743269A1 Methods and kits for enhancing ability to learn in a puppy or kitten |
| 04/14/2005 | CA2582437A1 Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| 04/14/2005 | CA2582018A1 Buccal, polar and non-polar spray containing zolpidem |
| 04/14/2005 | CA2582008A1 Buccal, polar and non-polar spray containing sumatriptan |
| 04/14/2005 | CA2582007A1 Buccal, polar and non-polar spray containing diazepam |
| 04/14/2005 | CA2554954A1 Buccal, polar and non-polar spray containing ondansetron |
| 04/14/2005 | CA2545479A1 Compounds comprising a nitric oxide moiety for inducing expression of apoa1 for the treatment of cardiovascular disorders |
| 04/14/2005 | CA2544574A1 Stable vitamin b6 derivative |
| 04/14/2005 | CA2542021A1 Dmbt1 as a clinical marker and uses thereof |
| 04/14/2005 | CA2542002A1 Methods for modulating neuronal responses using inhibitors of ampa receptor endocytosis |
| 04/14/2005 | CA2541533A1 New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1 |
| 04/14/2005 | CA2541530A1 Somatostatin receptor 1 and/or 4 selective agonists and antagonists |
| 04/14/2005 | CA2541302A1 Ophthalmic composition for treating tear dysfunction |
| 04/14/2005 | CA2541299A1 Amide compounds as ion channel ligands and uses thereof |
| 04/14/2005 | CA2541020A1 Hypo- and hyper-acetylated meningococcal capsular saccharides |
| 04/14/2005 | CA2541014A1 Spirocyclic heterocyclic derivatives and methods of their use |
| 04/14/2005 | CA2540895A1 Combinations of ziconotide and opioids for reducing pain |
| 04/14/2005 | CA2540890A1 Treatment of demyelinating autoimmune disease with modified ordered peptides |
| 04/14/2005 | CA2540828A1 Heterocyclic amides and sulfonamides |
| 04/14/2005 | CA2540742A1 Compositions and methods for treating burns |
| 04/14/2005 | CA2540741A1 Agent for treating diabetes |
| 04/14/2005 | CA2540699A1 Polysaccharides for pulmonary delivery of active agents |
| 04/14/2005 | CA2540697A1 Extended triphasic contraceptive regimens |
| 04/14/2005 | CA2540681A1 Methods for altering mrna splicing and treating familial dysautonomia and other mechanistically related disorders |
| 04/14/2005 | CA2540671A1 Infusion preparation containing (2r)-2-propyloctanoic acid as the active ingredient |
| 04/14/2005 | CA2540670A1 Drug containing (2r)-2-propyloctanoic acid as the active ingredient |
| 04/14/2005 | CA2540666A1 Glucocerebroside treatment of disease |
| 04/14/2005 | CA2540640A1 Vanilloid receptor ligands and their use in treatments |